Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.

MLA

Frenck, Robert W., Jr, et al. “Comparison of the Immunogenicity and Safety of a Split-Virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal and Intramuscular Route in Healthy Adults.” Vaccine, vol. 29, no. 34, Aug. 2011, pp. 5666–74. EBSCOhost, https://doi.org/10.1016/j.vaccine.2011.06.010.

APA

Frenck, R. W., Jr, Belshe, R., Brady, R. C., Winokur, P. L., Campbell, J. D., Treanor, J., Hay, C. M., Dekker, C. L., Walter, E. B., Jr, Cate, T. R., Edwards, K. M., Hill, H., Wolff, M., Leduc, T., & Tornieporth, N. (2011). Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. Vaccine, 29(34), 5666–5674. https://doi.org/10.1016/j.vaccine.2011.06.010

Chicago

Frenck, Robert W, Jr, Robert Belshe, Rebecca C Brady, Patricia L Winokur, James D Campbell, John Treanor, Christine M Hay, et al. 2011. “Comparison of the Immunogenicity and Safety of a Split-Virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal and Intramuscular Route in Healthy Adults.” Vaccine 29 (34): 5666–74. doi:10.1016/j.vaccine.2011.06.010.